Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.
about
Tumor size classification of the 8th edition of TNM staging system is superior to that of the 7th edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy.Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?
P2860
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Genomics-Driven Precision Medi ...... esults from the COMPASS Trial.
@en
Genomics-Driven Precision Medi ...... esults from the COMPASS Trial.
@nl
type
label
Genomics-Driven Precision Medi ...... esults from the COMPASS Trial.
@en
Genomics-Driven Precision Medi ...... esults from the COMPASS Trial.
@nl
prefLabel
Genomics-Driven Precision Medi ...... esults from the COMPASS Trial.
@en
Genomics-Driven Precision Medi ...... esults from the COMPASS Trial.
@nl
P2093
P2860
P50
P1476
Genomics-Driven Precision Medi ...... Results from the COMPASS Trial
@en
P2093
Ashton A Connor
Bernadette Southwood
Danielle Pasternack
David Hedley
Dianne Chadwick
Faiyaz Notta
Faridah Mbabaali
Grainne M O'Kane
P2860
P304
P356
10.1158/1078-0432.CCR-17-2994
P407
P577
2017-12-29T00:00:00Z